Advertisement
  1. Business

Shareholder sues Apyx Medical of Clearwater over stock drop

Apyx Medical Corp., formerly Bovie Medical Corp., has its main offices on Ulmerton Road near the St. Pete-Clearwater International Airport. RICHARD DANIELSON | Times
Published Apr. 19

CLEARWATER — A shareholder this week sued surgical device maker Apyx Medical in federal court, contending that the price of the company's stock plunged after Apyx misled investors, then belatedly shared bad news about a clinical test of its signature product.

The suit seeks class-action status and was filed in U.S. District Court in Tampa by stockholder Kyle Pritchard on behalf of others who bought Apyx stock from Aug. 1, 2018 to this April 1. Along with the company, which was known as Bovie Medical until January, the suit names Apyx chief executive officer Charles D. Goodwin as a defendant.

"Apyx Medical Corp. is aware of the filing of the lawsuit," Apyx investor relations spokesman Mike Piccinino said in an email to the Tampa Bay Times on Friday. "While the company's policy is not to comment about ongoing litigation, the company intends to vigorously defend against this action."

MEANWHILE, IN TALLAHASSEE: Florida may boost regulation of cosmetic surgery clinics

Apyx, which is based on Ulmerton Road south of the St. Pete-Clearwater International Airport, makes a high-tech scalpel and surgical tool known as J-Plasma, which is sold under the Renuvion Cosmestic Technology brand, that surgeons can use to cut, coagulate and remove tissue during cosmetic surgery and other procedures with minimal effect to surrounding tissues.

The company announced in December that it was applying for regulatory approval to use J-Plasma in dermal resurfacing, a rejuvenation procedure that the American Society of Plastic Surgeons says can be used to treat wrinkles, spots, scars and other conditions. The study looked at the use of J-Plasma on reducing wrinkles in 55 patients treated at three different clinics. In January, Goodwin mentioned the clinical trial as a milestone that helped provide a bases for a "very positive" outlook for 2019.

But on Feb. 21, Pritchard's suit notes, White Diamond Research, a stock research firm that sells information to hedge funds and wealthy investors, issued a report suggesting that the test results for J-Plasma were coming up short. In response, the company's share price fell nearly 25 percent to $6.40 a share "on unusually heavy trading volume" the same day, the suit contends.

Then, on April 1, Apyx disclosed that it had withdrawn its application to have regulators clear J-Plasma for dermal resurfacing as a result of concerns about the tests raised by the U.S. Food and Drug Administration. On that news, the suit adds, Apyx's saw more heavy trading that drove its share price down 36 percent to $4.46 per share when the market closed the following day.

In its disclosure on April 1 Apyx said the clinical test "yielded no serious adverse events." It did acknowledge that results fell short of the study's goal and that the FDA raised an issue about the consistency of the results. First, 75 percent of patients were expected to see a pre-determined quantifiable improvement in their appearance as measured against a standard scale used to assess the results of plastic surgery, but only 62 percent achieved the required score. Also, test results appeared to be better coming from one testing center than from two others.

"We are actively engaged with the agency to determine what additional data, studies and analyses may be required" for another clinical test to determine whether J-Plasma could be used in dermal resurfacing procedures, Goodwin said in the company's announcement on April 1.

Pritchard's suit contends that Apyx and Goodwin made false or misleading statements. Failing to share the bad news about the clinical trial sooner meant that the company's optimistic expectations "lacked a reasonable basis," the suit says, and as the value of the stock fell, Pritchard and other stockholders "suffered significant losses and damages." The suit, filed by law firms in Vero Beach and Los Angeles, seeks an unspecified amount of compensatory damages. Meanwhile, two other law firms in New York and Pennsylvania have announced that they are recruiting potential plaintiffs for a potential class-action lawsuit.

Friday afternoon, Apyx's stock was trading on the NASDAQ exchange at $3.85 a share, up nearly 5 percent.

MORE: Go here for more Business News

Contact Richard Danielson at rdanielson@tampabay.com or (813) 226-3403. Follow @Danielson_Times

ALSO IN THIS SECTION

  1. Frances Werner-Watkins Julie Rinaldi
    News and notes on local businesses
  2. Left to right: Oak Hill Hospital Anesthesiology residents Daniel Eskander, Wayne Simmons, Jeffrey Huang and Benjamin Segil. Katie Stacy/Oak Hill Hospital
    News and notes on local businesses
  3. A total of 131 employees are scheduled to be laid off in January as Locale Market and Farm Table Cucina close at the Sundial to make way for a new food hall created by the developers of the Heights Public Market at the Armature Works in Tampa. CHRIS URSO   |   TIMES
    In a notice to the state of Florida, Sundial owner Bill Edwards said the layoffs are expected to take place the first week of January.
  4. WeWork is opening Tampa offices at 501 E Kennedy Blvd. despite company struggles, including $1.25 billion in losses over 2019. SCOTT KEELER  |  Tampa Bay Times
    WeWork has 200 planned coworking space openings as leadership tries to manage $1.25 billion in losses.
  5. Florida's unemployment rate was unchanged in October at 3.2 percent, according to numbers released Friday. LYNNE SLADKY  |  AP
    The latest numbers were released Friday morning.
  6. Apollo Global Management has offered $130 per share for Tech Data's stock in an acquisition worth $5.4 billion. If regulators shareholders approve, the home-grown company will remain based in Pinellas County, where it employs 2,000 of its 14,000 workers. DIRK SHADD  |  Tampa Bay Times
    Private equity firms like Apollo create wealth for pension funds, financial institutions and individual investors by buying assets that typically are sold later at a profit.
  7. Some of Tampa Bay's largest companies are being sold or are up for sale. Times files and Bloomin' Brands
    Tech Data is just the latest in a growing list of public companies bought up by out-of-state firms.
  8. Hillsborough Community College solicited "non-binding letters of interest or intent” last month from developers interested in purchasing the Dr. Gwendolyn W. Stephenson District Administration Center on Davis Islands. OCTAVIO JONES  |  Times
    Developers have eyed the 3.7 acre waterfront parcel for years, but recent interest has prompted the college’s trustees to finally start the conversation.
  9. Tampa International Airport looking north. The Wall Street Journal ranked it the best midsize airport in America. [Times files]
    TPA took first place in the Wall Street Journal’s annual survey of U.S. airports.
  10. Tech Data's CEO Rich Hume (left) shares a moment with former CEO Bob Dutkowsky during a send off celebration for Dutkowsky earlier this year. JIM DAMASKE   |   Times
    A private equity firm has agreed to buy Tech Data.
Advertisement
Advertisement
Advertisement